3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Central Nervous System Neoplasms
3
Wilms Tumor
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Sarcoma, Ewing
1
Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion
1
Histiocytic Sarcoma
1
Interventions
Prednisone
112
Docetaxel
87
Leuprolide
79
enzalutamide
72
Abiraterone Acetate
67
bicalutamide
53
Goserelin
50
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
42
Radiotherapy
39
abiraterone
28
Magnetic Resonance Spectroscopy
27
Gonadotropin-Releasing Hormone
24
gallium 68 PSMA-11
23
apalutamide
22
Androgen Antagonists
22
luprolide acetate gel depot
21
sipuleucel-T
20
Radiosurgery
20
Triptorelin Pamoate
18
cabazitaxel
17
cabozantinib
16
Radiotherapy, Intensity-Modulated
16
Flutamide
16
pembrolizumab
15
radium Ra 223 dichloride
14
Prednisolone
14
Nivolumab
14
Dutasteride
14
Dexamethasone
14
Radiation
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Prostatic Neoplasms
×
larotrectinib
×
Clear all
No trials found.